Drug IndexIlaris (canakinumab)
Billing
Code: J0638
Description: Canakinumab injection
Unit: 1 MG
Payment: $124.484
Pay quarter: Q2 2024
Covered in Part D: No
Drug Cost
Calculate drug cost and reimbursement
Total WAC:
$17,815.52Total Reimbursement:
$18,672.60(ASP: $17,615.66, Margin: $1,056.94)
.
.# Units to bill:
150Dosage & Frequency
Cryopyrin-Associated Periodic Syndromes (CAPS)
• 150mg SQ every 8 weeks if patient weighs more than 40kg
• 2mg/kg SQ every 8 weeks if patient weighs between 15-40kg
• 150mg SQ every 8 weeks if patient weighs more than 40kg
• 2mg/kg SQ every 8 weeks if patient weighs between 15-40kg
Tumor Necrosis Factor Receptor (TNF) Associated Periodic Syndrome (TRAPS)
Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD)
Familial Mediterranean Fever (FMF)
• 2mg/kg SQ every 4 weeks if patient weighs 40kg or below
• 150mg SQ every 4 weeks if patient weighs more than 40kg
Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD)
Familial Mediterranean Fever (FMF)
• 2mg/kg SQ every 4 weeks if patient weighs 40kg or below
• 150mg SQ every 4 weeks if patient weighs more than 40kg
Still's Disease
• 4mg/kg (not to exceed 300mg) SQ every 4 weeks
• 4mg/kg (not to exceed 300mg) SQ every 4 weeks
Billable NDCs
00078-0734-61
ILARIS (NOVARTIS PHARMACEUTICALS CORPORATION)
150 MG
Prior Authorization
Resources